WINTON GROUP Ltd Acquires New Position in UnitedHealth Group Incorporated (NYSE:UNH)

WINTON GROUP Ltd purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,012 shares of the healthcare conglomerate's stock, valued at approximately $1,018,000.

Other hedge funds have also modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 6.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,740,072 shares of the healthcare conglomerate's stock valued at $1,405,662,000 after buying an additional 156,851 shares during the period. Foundation Wealth Management LLC PA acquired a new position in UnitedHealth Group in the 4th quarter valued at about $835,000. Tyler Stone Wealth Management grew its stake in UnitedHealth Group by 6.7% in the 4th quarter. Tyler Stone Wealth Management now owns 1,365 shares of the healthcare conglomerate's stock worth $691,000 after acquiring an additional 86 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its position in UnitedHealth Group by 42.8% during the fourth quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 117,588 shares of the healthcare conglomerate's stock worth $59,483,000 after buying an additional 35,259 shares during the period. Finally, Aviso Wealth Management grew its holdings in UnitedHealth Group by 59.2% in the fourth quarter. Aviso Wealth Management now owns 1,328 shares of the healthcare conglomerate's stock valued at $672,000 after purchasing an additional 494 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock traded down $0.50 on Tuesday, hitting $523.25. The company had a trading volume of 1,472,630 shares, compared to its average volume of 4,744,426. The firm has a market capitalization of $478.62 billion, a P/E ratio of 33.76, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a 50-day moving average of $509.10 and a 200-day moving average of $543.47. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.61%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.